Rare diseases
Investigational molecules
Locations
Back to Bulgaria100 clinical trials in Burgas, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.
Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
BulgariaA study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness
BulgariaLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
BulgariaStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
BulgariaStudy of evenamide as add-on treatment for patients with treatment-resistant schizophrenia not adequately controlled by current antipsychotic medications
BulgariaStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
BulgariaStudy on Seltorexant for Adults and Elderly with Major Depressive Disorder and Insomnia Symptoms
BulgariaStudy on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
BulgariaStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
BulgariaStudy on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease
BulgariaStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
BulgariaStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on lung cancer and breast cancer treatments, including studies of novel therapies for metastatic conditions. Research encompasses both targeted and immunotherapy approaches.
Emphasis on developing treatments for patients with specific genetic markers and testing new combination therapies.
Comprehensive research into cardiovascular disease prevention and treatment, including innovative approaches to managing atherosclerosis and stroke prevention.
Multiple trials evaluating new compounds for lipid management and cardiovascular risk reduction.
Studies focused on chronic respiratory conditions including COPD and asthma, testing advanced inhalation therapies and novel treatment approaches.
Investigation of new therapeutic combinations and delivery systems for respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
